PMC:7534795 / 30598-30795 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T152","span":{"begin":150,"end":157},"obj":"Body_part"}],"attributes":[{"id":"A152","pred":"fma_id","subj":"T152","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"latelet activation in COVID-19 patients.\nPharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference\n• Heparin anticoagulant treatment in sepsis-induc"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T247","span":{"begin":22,"end":30},"obj":"Disease"}],"attributes":[{"id":"A247","pred":"mondo_id","subj":"T247","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"latelet activation in COVID-19 patients.\nPharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference\n• Heparin anticoagulant treatment in sepsis-induc"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T64675","span":{"begin":8,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"latelet activation in COVID-19 patients.\nPharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference\n• Heparin anticoagulant treatment in sepsis-induc"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T225","span":{"begin":150,"end":157},"obj":"Chemical"},{"id":"T226","span":{"begin":158,"end":171},"obj":"Chemical"}],"attributes":[{"id":"A225","pred":"chebi_id","subj":"T225","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A226","pred":"chebi_id","subj":"T226","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"}],"text":"latelet activation in COVID-19 patients.\nPharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference\n• Heparin anticoagulant treatment in sepsis-induc"}

{"project":"LitCovid-sentences","denotations":[{"id":"T212","span":{"begin":41,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"latelet activation in COVID-19 patients.\nPharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference\n• Heparin anticoagulant treatment in sepsis-induc"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T126","span":{"begin":185,"end":191},"obj":"Phenotype"}],"attributes":[{"id":"A126","pred":"hp_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/HP_0100806"}],"text":"latelet activation in COVID-19 patients.\nPharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference\n• Heparin anticoagulant treatment in sepsis-induc"}

{"project":"LitCovid-PubTator","denotations":[{"id":"970","span":{"begin":150,"end":157},"obj":"Chemical"},{"id":"986","span":{"begin":185,"end":191},"obj":"Disease"},{"id":"1007","span":{"begin":31,"end":39},"obj":"Species"},{"id":"1009","span":{"begin":22,"end":30},"obj":"Disease"}],"attributes":[{"id":"A970","pred":"tao:has_database_id","subj":"970","obj":"MESH:D006493"},{"id":"A986","pred":"tao:has_database_id","subj":"986","obj":"MESH:D018805"},{"id":"A1007","pred":"tao:has_database_id","subj":"1007","obj":"Tax:9606"},{"id":"A1009","pred":"tao:has_database_id","subj":"1009","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"latelet activation in COVID-19 patients.\nPharmacological intervention Sample size and criteria Treatment protocol Key findings Conclusion Reference\n• Heparin anticoagulant treatment in sepsis-induc"}